Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation - A report from the Societe Francaise de Greffe de Moelle

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2238-2246

  Michel, G ^a   Socie G ^a   Gebhard, F ^a   Bernaudin, F ^a   Thuret, I ^a   Vannier, J P ^a   Demeocq, F ^a   Leverger, G ^a   Pico, J L ^a   Rubie, H ^a   Mechinaud, F ^a   Reiffers, J ^a   Gratecos, N ^a   Troussard, X ^a   Jouet, J P ^a   Simonin, G ^a   Gluckman, E ^a   Maraninchi, D ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CATARACT; CELL FUNCTION; CHILD; FOLLOW UP; GROWTH RETARDATION; HEART DISEASE; HUMAN; HYPOTHYROIDISM; LEYDIG CELL; MAJOR CLINICAL STUDY; OVARY DISEASE; PRIORITY JOURNAL; THYROID DISEASE; WHOLE BODY RADIATION;

EID: 0030902377     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2238     Document Type: Article

References (52)

1. Amadori S, Testi AM, Arico M, et al: Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 11:1046-1054, 1993
2. Nesbit ME, Buckley JD, Feig SA, et al: Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: A report from the Childrens Cancer Group. J Clin Oncol 12:127-135, 1994
3. Dahl GV, Kalwinski DK, Mirro J. et al: Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8:295-303, 1990
4. Wells RJ, Woods WG, Buckley JD, et al: Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Childrens Cancer Group study. J Clin Oncol 12:2367-2377, 1994
5. Michel G, Leverger G, Leblanc T, et al: Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Bone Marrow Transplant 17:191-196, 1996
6. Woods WG, Neudorf S, Gold S. et al: Aggressive post-remission chemotherapy is better than autologous bone marrow transplantation and allogeneic BMT is superior to both in children with acute myeloid leukemia. Proc Am Soc Clin Oncol 15:368a, 1996 (abstr)
7. Michel G, Gluckman E, Blaise D, et al: Improvement in outcome for children receiving allogeneic bone marrow transplantation in first complete remission of acute myeloid leukemia. A report from the GEGMO. J Clin Oncol 10:1865-1869, 1992
8. Feig SA, Lampkin B, Nesbit ME, et al: Outcome of BMT during first complete remission of AML: A comparison of two sequential studies by the Childrens Cancer Group. Bone Marrow Transplant 12:65-71, 1993
9. Willi SM, Cooke K, Goldwein J, et al: Growth in children after bone marrow transplantation for advanced neuroblastoma compared with growth after transplantation for leukemia or aplastic anemia. J Pediatr 120:726-732, 1992
10. Huma Z, Boulad F, Black P, et al: Growth in children after bone marrow transplantation for acute leukemia. Blood 86:819-824, 1995
11. Alter CA, Thornton PS, Willi SM, et al: Growth in children after bone marrow transplantation for acute myelogenous leukemia as compared to acute lymphocytic leukemia. J Pediatr Endocrinol Metab 9:51-57, 1996
12. Copeland EA, Biggs JC, Thompson JM, et al: Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with Bu-Cy2. Blood 78:838-843, 1991
13. Santos GW, Tutschka PJ, Brookmeyer R, et al: Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulphan and cyclophosphamide. N Engl J Med 309:1347-1353, 1983
14. Michel G, Gluckman E, Esperou-Bourdeau H, et al: Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: Impact of conditioning regimen without total body irradiation. A report from the Sociètè Française de Greffe de Moelle. J Clin Oncol 12:1217-1222, 1994
15. Sempé P. Pédron G, Roy-Pernot MP: Auxologie, Méthodes et Séquences. Paris, France, Theraplix, 1979
16. Sanders JE, Pritchard S, Mahoney P, et al: Growth and development following marrow transplantation for leukemia. Blood 68:1129-1135, 1986
17. Sanders JE, Buckner CD, Sullivan KM, et al: Growth and development in children after bone marrow transplantation. Horm Res 30:92-97, 1988
18. Sanders JE: The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 28:244-249, 1991
19. Sanders JE: Endocrine problems in children after bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 8:2-4, 1991 (suppl 1)
20. Borgström B, Bolme P: Growth and growth hormone in children after bone marrow transplantation. Horm Res 30:98-100, 1988
21. Bushhouse S, Ramsay NK, Pescovitz OH, et al: Growth in children following irradiation for bone marrow transplantation. Am J Pediatr Hematol Oncol 11:134-140, 1989
22. Brauner R, Fontoura M, Zucker JM, et al: Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 68:458-463, 1993
23. Thomas BC, Stanhope R, Plowman PN, et al: Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 152:888-892, 1993
24. Sklar C: Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr 411:57-61, 1995 (suppl)
25. Wingard JR, Plotnick LP, Freemer CS, et al: Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79:1068-1073, 1992
26. Bozzola M, Giorgiani G, Locatelli F, et al: Growth in children after bone marrow transplantation. Horm Res 39:122-126, 1993
27. Giorgiani G, Bozzola M, Locatelli F, et al: Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86:825-831, 1995
28. Leisner RJ, Leiper AD, Hann IM, et al: Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 12:916-924, 1994
29. De Sanctis V, Galimberti M, Lucarelli G, et al: Gonadal function after allogeneic bone marrow transplantation for thalassemia. Arch Dis Child 66:517-520, 1991
30. Sklar CA, Tim TH, Ramsay NK, et al: Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med 73:688-694, 1982
31. Leiper AD, Stahope R, Lau T, et al: The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 67:419-426, 1987
32. Katsanis E, Shapiro RS, Pobison LL, et al: Thyroid dysfunction following bone marrow transplantation: Long term follow-up of 80 pediatric patients. Bone Marrow Transplant 5:335-340, 1990
33. Ogilvy-Stuart AL, Clark DJ, Wallace WHB, et al: Endocrine deficit after fractionated total body irradiation. Arch Dis Child 67:1107-1110, 1992
34. Carlson K, Lönnerholm G, Smedmyr B, et al: Thyroid function after autologous bone marrow transplantation. Bone Marrow Transplant 10:123-127, 1992
35. Borgström B, Bolme P: Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 13:59-64, 1994
36. Boulad F, Bromley M, Black P, et al: Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 15:71-76, 1995
37. Sanders JE: Growth and development after bone marrow transplantation, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, pp 527-537
38. Manenti F, Galimberti M, Lucarelli G, et al: Growth and endocrine function after bone marrow transplantation for thalassemia, in Bucker CD, Gale RP, Lucarelli G (eds): Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches. New York, NY, Liss, 1989, pp 273-280
39. Urban C, Schwingshandl J, Slave I, et al: Endocrine function after bone marrow transplantation without the use of total body irradiation. Bone Marrow Transplant 3:291-296, 1988
40. Steinherz LJ, Graham T, Hurwitz R, et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report from the cardiology committee of the Childrens Cancer Study Group. Pediatrics 89:942-949, 1992
41. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
42. Goorin AM, Chauvenet AR, Perez-Atayde AR, et al: Initial congestive heart failure, six to ten years after doxorubicin therapy for childhood cancer. J Pediatr 116:144-147, 1990
43. Deeg J, Flournoy N, Sullivan KM, et al: Cataract after total body irradiation and marrow transplantation: A sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10:957-964, 1984
44. Livesey SJ, Holmes JA, Whittaker JA: Ocular complications of bone marrow transplantation. Eyes 3:271-276, 1989
45. Kim TH, McGlave PB, Ramsay N, et al: Comparison of two total body irradiation regimen in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys 19:889-897, 1990
46. Calissendorf B, Bolme P, El Azazzi M: The development of cataract in children as late side-effect of bone marrow transplantation. Bone Marrow Transplant 7:427-429, 1991
47. Bray LC, Carey PJ, Proctor SJ, et al: Ocular complications of bone marrow transplantation. Br J Ophthalmol 75:611-614, 1991
48. Blaise D, Maraninchi D, Archimbaud E, et al: Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: A randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: A report from the Groupe d'Etude de la Greffe de Moelle Osseuse. Blood 79:2578-2582, 1992
49. Grochow LB, Jones RJ, Brundrett RB, et al: Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 25:55-61, 1989
50. Grochow LB, Krivit W, Whitley CB, et al: Busulfan disposition in children. Blood 75:1723-1727, 1990
51. Hassan M, Oberg G, Bekassy AN, et al: Pharmacokinetics of high-dose busulfan in relation to age and chronopharmacology. Cancer Chemother Pharmacol 28:130, 1991
52. 2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 79:2475-2479, 1992